World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
63468
World Ranking
4142
National Ranking
2269

Neuroscience

D-Index
117
Citations
63429
World Ranking
418
National Ranking
248

Martin R. Farlow publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Martin R. Farlow sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 619 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Martin R. Farlow D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Martin R. Farlow sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 117 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Martin R. Farlow is affiliated with Indiana University in the United States and has made notable contributions within the field of Medicine, focusing primarily on areas such as Physiology, Psychiatry and Mental Health, Molecular Biology, Cognitive Neuroscience, and Neurology.

Their research covers a range of topics, including:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Functional Brain Connectivity Studies
  • Bioinformatics and Genomic Networks
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Advanced Neuroimaging Techniques and Applications
  • Health, Environment, Cognitive Aging

Recent publications by Martin R. Farlow illustrate a focus on Alzheimer's disease and related neurological conditions. Selected papers include:

  • "A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease" (2020), published in Nature Medicine
  • "Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study" (2020), published in Nature Communications
  • "Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy" (2021), published in Nature
  • "A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease" (2021), published in Nature Medicine
  • "Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid" (2022), published in Nature

Frequent co-authors collaborating with Martin R. Farlow include:

  • Randall J. Bateman
  • Jasmeer P. Chhatwal
  • Carlos Cruchaga
  • John C. Morris
  • Eric McDade

Martin R. Farlow's research has been published across multiple prominent scientific venues, with frequent appearances in:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature Medicine
  • JAMA Neurology

Best Publications

  • Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Unknown

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

    S. L. Rogers;M. R. Farlow;R. S. Doody;R. Mohs

  • Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

    Pierre N. Tariot;Martin R. Farlow;George T. Grossberg;Stephen M. Graham

  • Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    RS Rachelle S. Doody;RG Ronald G. Rg Thomas;Martin Farlow;Takeshi Iwatsubo

  • The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

    Harald Hampel;M.-Marsel Mesulam;A Claudio Cuello;Martin R Farlow

  • Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

    Maria Grazia Spillantini;Jill R. Murrell;Michel Goedert;Martin R. Farlow

  • A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

    Jill Murrell;Martin Farlow;Bernardino Ghetti;Merrill D. Benson

  • A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    Rachelle S. Doody;Rema Raman;Martin Farlow;Takeshi Iwatsubo

  • A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

    Margaret J. Knapp;David S. Knopman;Paul R. Solomon;William W. Pendlebury

  • Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

    Piero Parchi;Rudolph Castellani;Sabina Capellari;Bernardino Ghetti

  • Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

    Paul S. Aisen;Kimberly A. Schafer;Michael Grundman;Eric Pfeiffer

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

    Oliver Preische;Oliver Preische;Stephanie A. Schultz;Anja Apel;Anja Apel;Jens Kuhle

  • A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

    Martin Farlow;Stephen I. Gracon;Linda A. Hershey;Karen W. Lewis

  • Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

    Judes Poirier;Marie Claude Delisle;Rémi Quirion;Isabelle Aubert

  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

    Nicolas R Barthélemy;Yan Li;Nelly Joseph-Mathurin;Brian A Gordon

  • Cerebrospinal Fluid Tau and β-Amyloid: How Well Do These Biomarkers Reflect Autopsy-Confirmed Dementia Diagnoses?

    Christopher M. Clark;Sharon Xie;Jesse Chittams;Douglas Ewbank

  • Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments

    Maria Grazia Spillantini;Michel Goedert;R. Anthony Crowther;Jill R. Murrell

  • A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

    Martin Farlow;Ravi Anand;John Messina;Richard Hartman

Frequent Co-Authors

Bernardino Ghetti
Bernardino Ghetti Indiana University
Andrew J. Saykin
Andrew J. Saykin Indiana University
Shannon L. Risacher
Shannon L. Risacher Indiana University
John C. Morris
John C. Morris Washington University in St. Louis
Liana G. Apostolova
Liana G. Apostolova Indiana University
Stephen Salloway
Stephen Salloway Brown University
Frederick W. Unverzagt
Frederick W. Unverzagt Indiana University
Randall J. Bateman
Randall J. Bateman Washington University in St. Louis
Tatiana Foroud
Tatiana Foroud Indiana University
Paul S. Aisen
Paul S. Aisen University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Neuroscience can open doors to many rewarding careers. For those who want to integrate psychology practice, pursuing online psyd programs accredited by apa is a pathway to becoming a licensed psychologist. These APA-accredited programs ensure rigorous training, even in an online format.

If you are interested in therapy and family dynamics, the best online mft programs offer a direct route to becoming a Marriage and Family Therapist. Many of these programs are designed for flexibility, enabling you to balance your studies with personal commitments.

Not everyone is ready for a doctorate. An online bachelor's degree in neuroscience or a related field can help you get started quickly, sometimes in less time than traditional programs. This is a practical path for those eager to enter the field or advance to graduate studies.

Thinking about long-term earning potential? Review the high paying degrees in health, science, and technology. Understanding the financial outcomes can help align your education with your career and lifestyle goals.

Best Scientists Citing Martin R. Farlow

Trending Scientists

Recently Published Articles